We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Allergan Patent For Zymar Not Valid: Apotex

Law360 (February 23, 2009, 12:00 AM EST) -- In a patent dispute over Allergan Inc.'s antibiotic Zymar, which is used to treat bacterial infections in the eye, Apotex Inc. is arguing that its proposed generic version would not infringe...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.